A. Marc Gillinov, MD, Eugene H. Blackstone, MD, Edward R

Slides:

Advertisements

Similar presentations

Tomislav Mihaljevic, MD, Edward R

Advertisements

Moderate Tricuspid Regurgitation With Left-Sided Degenerative Heart Valve Disease: To Repair or Not to Repair? Jose L. Navia, MD, Nicolas A. Brozzi,

Spinal cord protective strategies during descending and thoracoabdominal aortic aneurysm repair in the modern era: The role of intrathecal papaverine

A. Marc Gillinov, MD, Tomislav Mihaljevic, MD, Eugene H

Residual patient, anatomic, and surgical obstacles in treating active left-sided infective endocarditis Syed T. Hussain, MD, Nabin K. Shrestha, MD, Steven.

Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD

Surgical management of secondary tricuspid valve regurgitation: Annulus, commissure, or leaflet procedure? Jose L. Navia, MD, Edward R. Nowicki, MD,

Moderate Tricuspid Regurgitation With Left-Sided Degenerative Heart Valve Disease: To Repair or Not to Repair? Jose L. Navia, MD, Nicolas A. Brozzi,

Prognosis of patients removed from a transplant waiting list for medical improvement: Implications for organ allocation and transplantation for status.

Advising complex patients who require complex heart operations

Should lung transplantation be performed for patients on mechanical respiratory support? The US experience David P. Mason, MD, Lucy Thuita, MS, Edward.

A comprehensive review of the PARTNER trial

Lars G. Svensson, MD, PhD, Lillian H. Batizy, MS, Eugene H

Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis Christophe de Meester, MS, Agnès Pasquet,

Beyond the Aortic Root: Staged Open and Endovascular Repair of Arch and Descending Aorta in Patients With Connective Tissue Disorders Eric E. Roselli,

Endovascular versus open elephant trunk completion for extensive aortic disease Eric E. Roselli, MD, Sreekumar Subramanian, MD, Zhiyuan Sun, BS, Jahanzaib.

The least of 3 evils: Exposure to red blood cell transfusion, anemia, or both? Gabriel Loor, MD, Jeevanantham Rajeswaran, PhD, Liang Li, PhD, Joseph F.

Mitral Valve Surgery in the Adult Marfan Syndrome Patient

Surgical treatment of pseudoaneurysm of the thoracic aorta

Surgical Treatment of Postinfarction Left Ventricular Pseudoaneurysm

Reoperation After Mitral Valve Repair for Degenerative Disease

Clostridium difficile infection after cardiac surgery: Prevalence, morbidity, mortality, and resource utilization Suresh Keshavamurthy, MBBS, MS, Colleen.

Coronary artery bypass grafting in diabetics: A growing health care cost crisis Sajjad Raza, MD, Joseph F. Sabik, MD, Ponnuthurai Ainkaran, MS, Eugene.

Surgical Repair of Posterior Mitral Valve Prolapse: Implications for Guidelines and Percutaneous Repair Douglas R. Johnston, MD, A. Marc Gillinov, MD,

Effects of right ventricular morphology and function on outcomes of patients with degenerative mitral valve disease Ying Ye, BS, Ravi Desai, MD, Lina.

Albert S. Y. Chang, MD, Nicholas G. Smedira, MD, Catherine L

Should lung transplantation be performed using donation after cardiac death? The United States experience David P. Mason, MD, Lucy Thuita, MS, Joan M.

Charles M. Wojnarski, MD, Lars G. Svensson, MD, PhD, Eric E

Spinal cord protective strategies during descending and thoracoabdominal aortic aneurysm repair in the modern era: The role of intrathecal papaverine

Does a similar procedure result in similar survival for women and men undergoing isolated coronary artery bypass grafting? Tamer Attia, MD, MSc, Colleen.

Simple versus complex degenerative mitral valve disease

Mechanical valves versus the Ross procedure for aortic valve replacement in children: Propensity-adjusted comparison of long-term outcomes Bahaaldin.

Capturing echocardiographic allograft valve function over time after allograft aortic valve or root replacement M. Mostafa Mokhles, PhD, MSc, Jeevanantham.

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

Gabriel Loor, MD, Liang Li, PhD, Joseph F

Atrial fibrillation complicating lung cancer resection

Long-Term Durability of Bicuspid Aortic Valve Repair

A. Marc Gillinov, MD, Patrick M. McCarthy, MD, Eugene H

del Nido versus Buckberg cardioplegia in adult isolated valve surgery

Outcomes of less invasive J-incision approach to aortic valve surgery

Nicholas G. Smedira, MD, Katherine J. Hoercher, RN, Dustin Y

David P. Mason, MD, Lillian H. Batizy, MS, Jeffrey Wu, MD, Edward R

Lars G. Svensson, MD, PhD, Gregory D

Distal aortic interventions after repair of ascending dissection: The argument for a more aggressive approach Eric E. Roselli, MD, Gabriel Loor, MD,

Edward R. Nowicki, MD, MS, Gösta B. Pettersson, MD, PhD, Nicholas G

Outcomes of a Less-Invasive Approach for Proximal Aortic Operations

Comparative study of bronchial artery revascularization in lung transplantation Gösta B. Pettersson, MD, PhD, Karam Karam, MD, Lucy Thuita, MS, Douglas.

Sudish C. Murthy, MD, PhD, Edward R. Nowicki, MD, MS, David P

Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration.

Decision support in surgical management of ischemic cardiomyopathy

Bahaaldin Alsoufi, MD, Cedric Manlhiot, BSc, Brian W

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Lars G. Svensson, MD, PhD, Fernando A. Atik, MD, Delos M

Colleen G. Koch, MD, MS, MBA, Edward R

Characteristics and long-term outcomes of contemporary patients with bicuspid aortic valves Ahmad Masri, MD, Vidyasagar Kalahasti, MD, Saqer Alkharabsheh,

Ventilatory dependency after cardiovascular surgery

Joseph F. Sabik, MD, Gabriel Olivares, MD, Sajjad Raza, MD, Bruce W

Douglas R. Johnston, MD, Edward G

Endocarditis after mitral valve repair

Turki B. Albacker, MD, MSc, Eugene H. Blackstone, MD, Sarah J

Surgery for rheumatic tricuspid valve disease: A 30-year experience

Mitral valve repair with aortic valve replacement is superior to double valve replacement A.Marc Gillinov, MD, Eugene H Blackstone, MD, Delos M Cosgrove,

Siva Raja, MD, PhD, Jay J. Idrees, MD, Eugene H

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Pulmonary hypertension is associated with worse early and late outcomes after aortic valve replacement: Implications for transcatheter aortic valve replacement

National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements Abby J. Isaacs, MS, Jeffrey Shuhaiber,

Identifying risk factors: Challenges of separating signal from noise

Lung Transplantation for Idiopathic Pulmonary Fibrosis

Fernando A. Atik, MD, Lars G. Svensson, MD, PhD, FACC, Eugene H

Presentation transcript:

Valve repair versus valve replacement for degenerative mitral valve disease A. Marc Gillinov, MD, Eugene H. Blackstone, MD, Edward R. Nowicki, MD, Worawong Slisatkorn, MD, Ghannam Al-Dossari, MD, Douglas R. Johnston, MD, Kristopher M. George, MD, Penny L. Houghtaling, MS, Brian Griffin, MD, Joseph F. Sabik, MD, Lars G. Svensson, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 135, Issue 4, Pages 885-893.e2 (April 2008) DOI: 10.1016/j.jtcvs.2007.11.039 Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Factors associated with mitral valve repair versus replacement. Raw grouped frequencies (closed circles) and trend (solid line). A, Time trend for mitral valve repair. B, Age trend for mitral valve repair. The Journal of Thoracic and Cardiovascular Surgery 2008 135, 885-893.e2DOI: (10.1016/j.jtcvs.2007.11.039) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Unadjusted survival after mitral valve repair (blue) or replacement (red) compared with age and sex-matched US population (dot-dash curves). Each symbol represents a death, and vertical bars are 68% actuarial confidence limits. Numbers in parentheses represent patients remaining at risk. Solid lines are parametric survival estimates enclosed within dashed 68% confidence limits. The Journal of Thoracic and Cardiovascular Surgery 2008 135, 885-893.e2DOI: (10.1016/j.jtcvs.2007.11.039) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Survival in propensity-matched patients having repair (blue) or replacement (red) compared with age-sex–matched US population (green). Format is as in Figure 2. The Journal of Thoracic and Cardiovascular Surgery 2008 135, 885-893.e2DOI: (10.1016/j.jtcvs.2007.11.039) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Survival in propensity-matched patients having repair (blue) or replacement (red) compared with unmatched patients having repair (orange) or replacement (black). Format is as in Figure 2. The Journal of Thoracic and Cardiovascular Surgery 2008 135, 885-893.e2DOI: (10.1016/j.jtcvs.2007.11.039) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Reoperation in propensity-matched patients after mitral valve repair (blue), replacement with bioprosthetic valve (red), or replacement with mechanical valve (black). Format of actuarial estimates is as in Figure 2. The Journal of Thoracic and Cardiovascular Surgery 2008 135, 885-893.e2DOI: (10.1016/j.jtcvs.2007.11.039) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Distribution of propensity scores among patients undergoing mitral valve repair or replacement. The Journal of Thoracic and Cardiovascular Surgery 2008 135, 885-893.e2DOI: (10.1016/j.jtcvs.2007.11.039) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions